|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 01/09 | Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target | MT |
| 07/08 | Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib | DJ |
| Market Cap | 77Cr 69Cr 64Cr 59Cr 110.33Cr 7.45TCr 111.85Cr 778.02Cr 301.18Cr 3.8TCr 290.7Cr 284.4Cr 12TCr | P/E 2026 * |
-8.14x | P/E 2027 * | -6.69x |
|---|---|---|---|---|---|
| Enterprise Value | 62Cr 55Cr 52Cr 47Cr 89Cr 5.98TCr 90Cr 624.18Cr 241.63Cr 3.05TCr 233.22Cr 228.16Cr 9.78TCr | EV / Sales 2026 * |
98x | EV / Sales 2027 * | 118x |
| Free-Float |
97.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACLS THER
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 17/01/2024 |
Hugh Davis
PSD | President | 67 | 18/11/2024 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 01/01/2023 |
Anand Mehra
BRD | Director/Board Member | 50 | 01/09/2014 |
| Director/Board Member | 59 | 01/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | -0.36% | +49.37% | +94.17% | 7.45TCr | |
| -0.61% | +0.69% | +36.36% | +82.72% | 6.01TCr | |
| -2.54% | -0.21% | +6.34% | +31.72% | 4.82TCr | |
| -2.99% | -5.20% | +27.94% | +34.48% | 4.43TCr | |
| +0.37% | +3.39% | +350.59% | +689.61% | 4.4TCr | |
| -1.81% | -0.32% | +7.06% | +101.03% | 4.16TCr | |
| +3.32% | +3.49% | +11.18% | +51.23% | 3TCr | |
| +4.77% | +6.16% | +36.77% | +22.78% | 2.93TCr | |
| -4.86% | -9.88% | -25.62% | +331.77% | 2.49TCr | |
| Average | +0.09% | +1.97% | +55.55% | +159.95% | 4.41TCr | |
| Weighted average by Cap. | +0.27% | +1.83% | +60.22% | +151.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.38L 56.3L 52.65L 47.98L 90.32L 61Cr 91.56L 6.37Cr 2.47Cr 31Cr 2.38Cr 2.33Cr 100Cr | 53.38L 47.41L 44.34L 40.4L 76.06L 51Cr 77.11L 5.36Cr 2.08Cr 26Cr 2Cr 1.96Cr 84Cr |
| Net income | -9.03Cr -8.02Cr -7.5Cr -6.84Cr -13Cr -869.7Cr -13Cr -91Cr -35Cr -442.93Cr -34Cr -33Cr -1.42TCr | -11Cr -9.98Cr -9.33Cr -8.5Cr -16Cr -1.08TCr -16Cr -112.88Cr -44Cr -550.84Cr -42Cr -41Cr -1.77TCr |
| Net Debt | -15Cr -14Cr -13Cr -12Cr -22Cr -1.47TCr -22Cr -153.84Cr -60Cr -750.72Cr -57Cr -56Cr -2.41TCr | -15Cr -13Cr -12Cr -11Cr -21Cr -1.41TCr -21Cr -147.26Cr -57Cr -718.6Cr -55Cr -54Cr -2.31TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
